R A Finley. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » HumansInfantMeningococcal Infections/immunologyMeningococcal Infections/prevention & controlMeningococcal Infections/transmissionPolysaccharides, BacterialRifampin/therapeutic useSulfadiazine/therapeutic useSulfonamides/therapeutic useVaccines
Substances: See more » Polysaccharides, BacterialSulfonamidesVaccinesSulfadiazineRifampin
Year: 1976 PMID: 778423 DOI: 10.1001/jama.236.5.459
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272